{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:06Z","timestamp":1787020626662,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060236"],"award-info":[{"award-number":["82060236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2023GXNSFAA026247"],"award-info":[{"award-number":["2023GXNSFAA026247"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02774-y","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T03:16:49Z","timestamp":1747106209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The characteristics of new-onset myasthenia gravis after COVID-19 outbreak: a cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yanzhen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianting","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2774_CR1","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","volume":"20","author":"A Dotan","year":"2021","unstructured":"Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20:102792.","journal-title":"Autoimmun Rev"},{"key":"2774_CR2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","volume":"173","author":"DA Restivo","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia Gravis Associated With SARS-CoV-2 Infection. Ann Intern Med. 2020;173:1027\u20138.","journal-title":"Ann Intern Med"},{"key":"2774_CR3","doi-asserted-by":"crossref","unstructured":"Cavalcante P, Bernasconi P, Mantegazza R. Autoimmune mechanisms in myasthenia gravis. Curr Opin Neurol. 2012;25:621\u20139.","DOI":"10.1097\/WCO.0b013e328357a829"},{"key":"2774_CR4","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/s41467-022-31951-8","volume":"13","author":"Y Yasumizu","year":"2022","unstructured":"Yasumizu Y, Ohkura N, Murata H, Kinoshita M, Funaki S, Nojima S, et al. Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma. Nat Commun. 2022;13:4230.","journal-title":"Nat Commun"},{"key":"2774_CR5","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00415-020-10149-2","volume":"268","author":"G Costamagna","year":"2021","unstructured":"Costamagna G, Abati E, Bresolin N, Comi GP, Corti S. Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic. J Neurol. 2021;268:1580\u201391.","journal-title":"J Neurol"},{"key":"2774_CR6","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","volume":"268","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. 2021;268:2690\u20136.","journal-title":"J Neurol"},{"key":"2774_CR7","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1111\/ene.14721","volume":"28","author":"A Assini","year":"2021","unstructured":"Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Del Sette M. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021;28:3537\u20139.","journal-title":"Eur J Neurol"},{"key":"2774_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00415-022-11472-6","volume":"270","author":"Y Tereshko","year":"2023","unstructured":"Tereshko Y, Gigli GL, Pez S, De Pellegrin A, Valente M. New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review. J Neurol. 2023;270:601\u20139.","journal-title":"J Neurol"},{"key":"2774_CR9","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.3346\/jkms.2022.37.e50","volume":"37","author":"MA Lee","year":"2022","unstructured":"Lee MA, Lee C, Park JH, Lee JH. Early-Onset Myasthenia Gravis Following COVID-19 Vaccination. J Korean Med Sci. 2022;37:e50.","journal-title":"J Korean Med Sci"},{"key":"2774_CR10","doi-asserted-by":"publisher","first-page":"e2789","DOI":"10.1002\/brb3.2789","volume":"12","author":"SMI Shah","year":"2022","unstructured":"Shah SMI, Yasmin F, Memon RS, Jatoi NN, Savul IS, Kazmi S, et al. COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2. Brain Behav. 2022;12:e2789.","journal-title":"Brain Behav"},{"key":"2774_CR11","doi-asserted-by":"crossref","unstructured":"Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK Antibody\u2013Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report. Ann Intern Med. 2021;:L20\u20131298.","DOI":"10.7326\/L20-1298"},{"key":"2774_CR12","doi-asserted-by":"crossref","unstructured":"Yuan K, Zheng Y-B, Wang Y-J, Sun Y-K, Gong Y-M, Huang Y-T, et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol Psychiatry. 2022;27:3214\u201322.","DOI":"10.1038\/s41380-022-01638-z"},{"key":"2774_CR13","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.2147\/JIR.S419307","volume":"16","author":"S Zhou","year":"2023","unstructured":"Zhou S, Wen Y, Liu C, Zhong J, Liang M, Wu Y, et al. Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study. J Inflamm Res. 2023;16:3157\u201368.","journal-title":"J Inflamm Res"},{"key":"2774_CR14","doi-asserted-by":"crossref","unstructured":"Muppidi S, Wolfe GI, Conaway M, Burns TM, Composite and the M, Group M-QS. MG-ADL: Still a relevant outcome measure. Muscle Nerve. 2011;44:727\u201331.","DOI":"10.1002\/mus.22140"},{"key":"2774_CR15","doi-asserted-by":"publisher","first-page":"95432","DOI":"10.18632\/oncotarget.20731","volume":"8","author":"P Cavalcante","year":"2017","unstructured":"Cavalcante P, Marcuzzo S, Franzi S, Galbardi B, Maggi L, Motta T, et al. Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? Oncotarget. 2017;8:95432\u201349.","journal-title":"Oncotarget"},{"key":"2774_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jhep.2018.01.040","volume":"68","author":"L Wang","year":"2018","unstructured":"Wang L, Gao F, Lin G, Yuan Y, Huang Y, Hao H, et al. Association of hepatitis E virus infection and myasthenia gravis: A pilot study. J Hepatol. 2018;68:1318\u201320.","journal-title":"J Hepatol"},{"key":"2774_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2018.09.015","volume":"395","author":"MA Hawkes","year":"2018","unstructured":"Hawkes MA, Hocker SE, Leis AA. West Nile virus induces a post-infectious pro-inflammatory state that explains transformation of stable ocular myasthenia gravis to myasthenic crises. J Neurol Sci. 2018;395:1\u20133.","journal-title":"J Neurol Sci"},{"key":"2774_CR18","first-page":"109.e7","volume":"25","author":"L Gong","year":"2019","unstructured":"Gong L, Li Y, Li X, Tu Q, Mou X, Wang S, et al. Detection of human parvovirus B19 infection in the thymus of patients with thymic hyperplasia-associated myasthenia gravis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2019;25:109.e7-109.e12.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"2774_CR19","first-page":"1164","volume":"22","author":"S Blum","year":"2015","unstructured":"Blum S, Lee D, Gillis D, McEniery DF, Reddel S, McCombe P. Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci Off J Neurosurg Soc Australas. 2015;22:1164\u20139.","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"2774_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/medicina60010056","volume":"60","author":"OA Mihalache","year":"2023","unstructured":"Mihalache OA, Vilciu C, Petrescu D-M, Petrescu C, Manea MC, Ciobanu AM, et al. Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients. Medicina (Mex). 2023;60:56.","journal-title":"Medicina (Mex)"},{"key":"2774_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12883-023-03486-y","volume":"23","author":"A Tayebi","year":"2023","unstructured":"Tayebi A, Samimisedeh P, Jafari Afshar E, Mahmoudnia S, Milan N, Ayati A, et al. Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients. BMC Neurol. 2023;23:437.","journal-title":"BMC Neurol"},{"key":"2774_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ana.25267","volume":"84","author":"D He","year":"2018","unstructured":"He D, Zhang H, Xiao J, Zhang X, Xie M, Pan D, et al. Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis. Ann Neurol. 2018;84:386\u2013400.","journal-title":"Ann Neurol"},{"key":"2774_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12883-018-1233-y","volume":"18","author":"JY Chung","year":"2018","unstructured":"Chung JY, Lee SJ, Shin B-S, Kang HG. Myasthenia gravis following human papillomavirus vaccination: a case report. BMC Neurol. 2018;18:222.","journal-title":"BMC Neurol"},{"key":"2774_CR24","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1080\/21645515.2021.1977580","volume":"17","author":"F Wang","year":"2021","unstructured":"Wang F, Xiang T, He L, Wang J. Laryngeal myasthenia gravis following influenza vaccination: a case report and literature review. Hum Vaccines Immunother. 2021;17:5529\u201331.","journal-title":"Hum Vaccines Immunother"},{"key":"2774_CR25","doi-asserted-by":"publisher","first-page":"733418","DOI":"10.3389\/fimmu.2021.733418","volume":"12","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Zhou R, Yang H, Yang H. To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis. Front Immunol. 2021;12:733418.","journal-title":"Front Immunol"},{"key":"2774_CR26","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2105-15-S6-S3","volume":"15 Suppl 6 Supp","author":"RD Melamed","year":"2014","unstructured":"Melamed RD, Khiabanian H, Rabadan R. Data-driven discovery of seasonally linked diseases from an Electronic Health Records system. BMC Bioinformatics. 2014;15 Suppl 6 Suppl 6:S3.","journal-title":"BMC Bioinformatics."},{"key":"2774_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13023-023-02727-0","volume":"18","author":"M Mahic","year":"2023","unstructured":"Mahic M, Bozorg A, DeCourcy J, Golden K, Gibson G, Taylor C, et al. Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. Orphanet J Rare Dis. 2023;18:169.","journal-title":"Orphanet J Rare Dis"},{"key":"2774_CR28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/cns.13468","volume":"26","author":"C Zhang","year":"2020","unstructured":"Zhang C, Bu B, Yang H, Wang L, Liu W, Duan R-S, et al. Immunotherapy choice and maintenance for generalized myasthenia gravis in China. CNS Neurosci Ther. 2020;26:1241\u201354.","journal-title":"CNS Neurosci Ther"},{"key":"2774_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamaneurol.2020.5407","volume":"78","author":"T Sharshar","year":"2021","unstructured":"Sharshar T, Porcher R, Demeret S, Tranchant C, Gueguen A, Eymard B, et al. Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial. JAMA Neurol. 2021;78:426\u201333.","journal-title":"JAMA Neurol"},{"key":"2774_CR30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41371-022-00726-5","volume":"36","author":"A \u00d6zcan","year":"2022","unstructured":"\u00d6zcan A, Avc\u0131 \u0130A. The influence of the pandemic on fear of contagion, blood pressure management and adherence to medication in hypertensive older adults in Turkey. J Hum Hypertens. 2022;36:852\u20139.","journal-title":"J Hum Hypertens"},{"key":"2774_CR31","first-page":"496","volume":"60","author":"S \u017dupani\u0107","year":"2022","unstructured":"\u017dupani\u0107 S, Lazibat I, Rubini\u0107 Majdak M, Jeli\u010di\u0107 M. Treatment of myasthenia gravis patients With COVID-19: review of the literature. Acta Clin Croat. 2022;60:496\u2013509.","journal-title":"Acta Clin Croat"},{"key":"2774_CR32","doi-asserted-by":"publisher","first-page":"102712","DOI":"10.1016\/j.autrev.2020.102712","volume":"20","author":"AM Lascano","year":"2021","unstructured":"Lascano AM, Lalive PH. Update in immunosuppressive therapy of myasthenia gravis. Autoimmun Rev. 2021;20:102712.","journal-title":"Autoimmun Rev"},{"key":"2774_CR33","doi-asserted-by":"publisher","first-page":"103071","DOI":"10.1016\/j.autrev.2022.103071","volume":"21","author":"A Dotan","year":"2022","unstructured":"Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. 2022;21:103071.","journal-title":"Autoimmun Rev"},{"key":"2774_CR34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/ene.14153","volume":"27","author":"CD Kassardjian","year":"2020","unstructured":"Kassardjian CD, Widdifield J, Paterson JM, Kopp A, Nagamuthu C, Barnett C, et al. Serious infections in patients with myasthenia gravis: population-based cohort study. Eur J Neurol. 2020;27:702\u20138.","journal-title":"Eur J Neurol"},{"key":"2774_CR35","doi-asserted-by":"publisher","first-page":"2100769","DOI":"10.1183\/13993003.00769-2021","volume":"59","author":"D Ward","year":"2022","unstructured":"Ward D, G\u00f8rtz S, Thomson Ernst M, Andersen NN, Kj\u00e6r SK, Hallas J, et al. The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection. Eur Respir J. 2022;59:2100769.","journal-title":"Eur Respir J"},{"key":"2774_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","volume":"18","author":"GI Wolfe","year":"2019","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo H-C, Marx A, et al. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol. 2019;18:259\u201368.","journal-title":"Lancet Neurol"},{"key":"2774_CR37","doi-asserted-by":"publisher","first-page":"32195","DOI":"10.1073\/pnas.2022901117","volume":"117","author":"RP Lisak","year":"2020","unstructured":"Lisak RP, Richman DP. Thymectomy and myasthenia gravis. Proc Natl Acad Sci U S A. 2020;117:32195\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2774_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13023-022-02454-y","volume":"17","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang Z, Zhang H, Cui Y, Chen Y, Lv P, et al. Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis. Orphanet J Rare Dis. 2022;17:309.","journal-title":"Orphanet J Rare Dis"},{"key":"2774_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000507853","volume":"83","author":"X Feng","year":"2020","unstructured":"Feng X, Huan X, Yan C, Song J, Lu J, Zhou L, et al. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China. Eur Neurol. 2020;83:182\u20138.","journal-title":"Eur Neurol"},{"key":"2774_CR40","doi-asserted-by":"publisher","first-page":"801255","DOI":"10.3389\/fmed.2022.801255","volume":"9","author":"WJ Li","year":"2022","unstructured":"Li WJ, Xue CL, Li Z. Impact of the COVID-19 Outbreak on Disease Spectrum of Pediatric Intensive Care Units. Front Med. 2022;9:801255.","journal-title":"Front Med"},{"key":"2774_CR41","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2020.6173","volume":"323","author":"H Sakamoto","year":"2020","unstructured":"Sakamoto H, Ishikane M, Ueda P. Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan. JAMA. 2020;323:1969\u201371.","journal-title":"JAMA"},{"key":"2774_CR42","doi-asserted-by":"publisher","first-page":"E177","DOI":"10.1148\/radiol.2021203153","volume":"299","author":"X Han","year":"2021","unstructured":"Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299:E177\u201386.","journal-title":"Radiology"},{"key":"2774_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis Nat Rev Dis Primer. 2019;5:30.","journal-title":"Myasthenia gravis Nat Rev Dis Primer"},{"key":"2774_CR44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp-2022-330519","volume":"94","author":"A Uzawa","year":"2023","unstructured":"Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, et al. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry. 2023;94:467\u201373.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2774_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","volume":"19","author":"C Nelke","year":"2022","unstructured":"Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter CB, Huntemann N, et al. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. J Neuroinflammation. 2022;19:89.","journal-title":"J Neuroinflammation"},{"key":"2774_CR46","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/acn3.51792","volume":"10","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang F, Long Z, Yang J, Ren Y, Ma Q, et al. Mortality of myasthenia gravis: a national population-based study in China. Ann Clin Transl Neurol. 2023;10:1095\u2013105.","journal-title":"Ann Clin Transl Neurol"},{"key":"2774_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"P Narayanaswami","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2021;96:114\u201322.","journal-title":"Neurology"},{"key":"2774_CR48","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1038\/s41598-023-30154-5","volume":"13","author":"M Tomschik","year":"2023","unstructured":"Tomschik M, Renaud E, J\u00e4ger F, Paternostro C, Rath J, Rinner W, et al. The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia gravis. Sci Rep. 2023;13:2985.","journal-title":"Sci Rep"},{"key":"2774_CR49","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/ene.14820","volume":"28","author":"R \u00c1lvarez-Velasco","year":"2021","unstructured":"\u00c1lvarez-Velasco R, Guti\u00e9rrez-Guti\u00e9rrez G, Trujillo JC, Mart\u00ednez E, Segovia S, Arribas-Velasco M, et al. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis. Eur J Neurol. 2021;28:2083\u201391.","journal-title":"Eur J Neurol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02774-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02774-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02774-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:04:38Z","timestamp":1747109078000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02774-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2774"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02774-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (2024-E420-01), and written informed consent was obtained from all patients before starting the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}